163 related articles for article (PubMed ID: 20559706)
1. Mumps and ovarian cancer: modern interpretation of an historic association.
Cramer DW; Vitonis AF; Pinheiro SP; McKolanis JR; Fichorova RN; Brown KE; Hatchette TF; Finn OJ
Cancer Causes Control; 2010 Aug; 21(8):1193-201. PubMed ID: 20559706
[TBL] [Abstract][Full Text] [Related]
2. Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.
Budiu RA; Mantia-Smaldone G; Elishaev E; Chu T; Thaller J; McCabe K; Lenzner D; Edwards RP; Vlad AM
Cancer Immunol Immunother; 2011 Jul; 60(7):975-84. PubMed ID: 21461842
[TBL] [Abstract][Full Text] [Related]
3. Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk.
Cramer DW; Williams K; Vitonis AF; Yamamoto HS; Stuebe A; Welch WR; Titus L; Fichorova RN
Cancer Causes Control; 2013 Nov; 24(11):1911-23. PubMed ID: 23925696
[TBL] [Abstract][Full Text] [Related]
4. Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.
Pinheiro SP; Hankinson SE; Tworoger SS; Rosner BA; McKolanis JR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1595-601. PubMed ID: 20501761
[TBL] [Abstract][Full Text] [Related]
5. Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls.
Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; van Zanten-Przybysz I; Hummel P; Nijman HW; Kenemans P; Hilgers J
Cancer Immunol Immunother; 1999 Apr; 48(1):47-55. PubMed ID: 10235488
[TBL] [Abstract][Full Text] [Related]
6. Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer.
Cramer DW; Titus-Ernstoff L; McKolanis JR; Welch WR; Vitonis AF; Berkowitz RS; Finn OJ
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1125-31. PubMed ID: 15894662
[TBL] [Abstract][Full Text] [Related]
7. CA125 immune complexes in ovarian cancer patients with low CA125 concentrations.
Cramer DW; O'Rourke DJ; Vitonis AF; Matulonis UA; Dijohnson DA; Sluss PM; Crum CP; Liu BC
Clin Chem; 2010 Dec; 56(12):1889-92. PubMed ID: 20943848
[TBL] [Abstract][Full Text] [Related]
8. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma-associated MUC1 detected by immunoradiometric assays.
Norum LF; Varaas T; Kierulf B; Nustad K
Tumour Biol; 1998; 19 Suppl 1():134-46. PubMed ID: 9422099
[TBL] [Abstract][Full Text] [Related]
10. Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.
Jeschke U; Wiest I; Schumacher AL; Kupka M; Rack B; Stahn R; Karsten U; Mayr D; Friese K; Dian D
Anticancer Res; 2012 May; 32(5):2185-9. PubMed ID: 22593508
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
Burford B; Gentry-Maharaj A; Graham R; Allen D; Pedersen JW; Nudelman AS; Blixt O; Fourkala EO; Bueti D; Dawnay A; Ford J; Desai R; David L; Trinder P; Acres B; Schwientek T; Gammerman A; Reis CA; Silva L; Osório H; Hallett R; Wandall HH; Mandel U; Hollingsworth MA; Jacobs I; Fentiman I; Clausen H; Taylor-Papadimitriou J; Menon U; Burchell JM
Br J Cancer; 2013 May; 108(10):2045-55. PubMed ID: 23652307
[TBL] [Abstract][Full Text] [Related]
12. Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival.
Dobrzanski MJ; Rewers-Felkins KA; Quinlin IS; Samad KA; Phillips CA; Robinson W; Dobrzanski DJ; Wright SE
Clin Immunol; 2009 Dec; 133(3):333-52. PubMed ID: 19762283
[TBL] [Abstract][Full Text] [Related]
13. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.
Ricardo S; Marcos-Silva L; Pereira D; Pinto R; Almeida R; Söderberg O; Mandel U; Clausen H; Felix A; Lunet N; David L
Mol Oncol; 2015 Feb; 9(2):503-12. PubMed ID: 25454345
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
Hermsen BB; Verheijen RH; Menko FH; Gille JJ; van Uffelen K; Blankenstein MA; Meijer S; van Diest PJ; Kenemans P; von Mensdorff-Pouilly S
Eur J Cancer; 2007 Jul; 43(10):1556-63. PubMed ID: 17532207
[TBL] [Abstract][Full Text] [Related]
15. Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.
Oei AL; Moreno M; Verheijen RH; Sweep FC; Thomas CM; Massuger LF; von Mensdorff-Pouilly S
Int J Cancer; 2008 Oct; 123(8):1848-53. PubMed ID: 18661524
[TBL] [Abstract][Full Text] [Related]
16. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.
Kenny L; O'Kelly E; Connell J; De Gascun C; Hassan J
J Clin Virol; 2016 Jan; 74():8-12. PubMed ID: 26630067
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity to mumps in a highly vaccinated population in Taiwan.
Ho YH; Tsai CC; Tsai YW; Wang YC; Lin TY; Lee DJ; Chen CJ
J Microbiol Immunol Infect; 2019 Jun; 52(3):379-385. PubMed ID: 29046249
[TBL] [Abstract][Full Text] [Related]
18. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
[TBL] [Abstract][Full Text] [Related]
19. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of the detection of IgA antibodies to the laboratory diagnosis of mumps in the population with a high vaccination coverage].
Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Malý M
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):16-9. PubMed ID: 25872991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
